Rafael Holdings (NYSE: RFL) is focused on the development of novel cancer therapies.  The Company is a significant investor in two clinical stage oncology companies-- Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd.

Biotechnology

Rafael Holdings

Rafael Holdings' headquarters in Newark, NJ, United States

William Conkling

David Polinsky

Ari Landon

Rachel Jonas

Michael J. Weiss

Boris C. Pasche

Howard S. Jonas

Stephen Greenberg

Mark McCamish

The Management team at Rafael Holdings is responsible for strategic oversight and direction within the company, guiding investment decisions and ensuring alignment with the mission to develop innovative cancer therapies. This team, composed of experienced directors and a dedicated Chairman, coordinates efforts across clinical-stage investments and fosters collaboration with portfolio companies to drive advancements in oncology research and development.

Management

Rafael Holdings

Org chart

Board & advisors

Teams

Management

Offices

Rafael Holdings

Org chart

Board & advisors

Teams

Management

Offices

Related companies